Literature DB >> 214220

Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines.

A L Epstein, R Levy, H Kim, W Henle, G Henle, H S Kaplan.   

Abstract

Ten consecutive diffuse histiocytic lymphoma (DHL) cell lines established in our laboratory were studied for the presence of Epstein-Barr virus (EBV) genomes, lysozyme, nonspecific esterase and other cytochemical reactions, phagocytic activity, cytoplasmic immunoglobulin light and heavy chains, and surface receptors to sheep erythrocytes, complement, and the Fc fragment of immunoglobulin. In agreement with previous studies performed on biopsy specimens, our results indicate that the diffuse histiocytic lymphomas, as a histopathologic entity, represent a heterogeneous group of neoplasms, the majority of which are B-lymphocyte in origin. The cell lines appear to fall into three categories based on the following criteria: 1) presence of monoclonal cytoplasmic immunoglobulins (B-lymphocytic type, 6/10 cell lines); 2) presence of non-specific esterase, phagocytic activity, and/or lysozyme (histiocytic type, 2/10 cell lines); and 3) absence of all lymphoid and histiocytic cell characteristics (null cell type, 2/10 cell lines). Despite the fact that many of the lymphoma patients had positive serologies to EBV antigens, all of the DHL cell lines were negative for the presence of EBV genomes. Both of the two B-lymphocytic type and one of the two histiocytic type lines tested were susceptible to infection with EBV, as indicated by synthesis of early antigen and also, in a small proportion of the infected cells, of viral capsid antigen. These prototypic DHL cell lines may permit the development of new criteria for the differential diagnosis and treatment of this highly malignant and diverse group of lymphomas.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214220     DOI: 10.1002/1097-0142(197811)42:5<2379::aid-cncr2820420539>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  37 in total

1.  Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells.

Authors:  Zenggang Pan; Yulei Shen; Cheng Du; Guimei Zhou; Andreas Rosenwald; Louis M Staudt; Timothy C Greiner; Timothy W McKeithan; Wing C Chan
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

2.  A monocyte/macrophage antigen recognized by the four antibodies GHI/61, Ber-MAC3, Ki-M8 and SM4.

Authors:  K Pulford; K Micklem; S McCarthy; J Cordell; M Jones; D Y Mason
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

3.  Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.

Authors:  Hong Duan; Caroline A Heckman; Linda M Boxer
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

4.  MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.

Authors:  Christian Steidl; Sohrab P Shah; Bruce W Woolcock; Lixin Rui; Masahiro Kawahara; Pedro Farinha; Nathalie A Johnson; Yongjun Zhao; Adele Telenius; Susana Ben Neriah; Andrew McPherson; Barbara Meissner; Ujunwa C Okoye; Arjan Diepstra; Anke van den Berg; Mark Sun; Gillian Leung; Steven J Jones; Joseph M Connors; David G Huntsman; Kerry J Savage; Lisa M Rimsza; Douglas E Horsman; Louis M Staudt; Ulrich Steidl; Marco A Marra; Randy D Gascoyne
Journal:  Nature       Date:  2011-03-02       Impact factor: 49.962

5.  Characterization of the reverse transcriptase of a type C RNA virus produced by a human lymphoma cell line.

Authors:  R S Goodenow; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

6.  Microarray analysis of B-cell lymphoma cell lines with the t(14;18).

Authors:  Ryan S Robetorye; Sandra D Bohling; John W Morgan; G Chris Fillmore; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

7.  Ultrastructural identification of neoplastic histiocytes--monocytes: an application of a newly developed cytochemical technique.

Authors:  H Kim; G A Pangalis; B C Payne; M E Kadin; H Rappaport
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

8.  Amyloid precursor-like protein 2 association with HLA class I molecules.

Authors:  Amit Tuli; Mahak Sharma; Xiaojian Wang; Laura C Simone; Haley L Capek; Steven Cate; William H Hildebrand; Naava Naslavsky; Steve Caplan; Joyce C Solheim
Journal:  Cancer Immunol Immunother       Date:  2009-01-31       Impact factor: 6.968

9.  Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.

Authors:  Richard Y Zhao; Dong Liang; Ge Li; Christopher W Larrimore; Bernard L Mirkin
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

10.  Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.

Authors:  Ryan D Morin; Nathalie A Johnson; Tesa M Severson; Andrew J Mungall; Jianghong An; Rodrigo Goya; Jessica E Paul; Merrill Boyle; Bruce W Woolcock; Florian Kuchenbauer; Damian Yap; R Keith Humphries; Obi L Griffith; Sohrab Shah; Henry Zhu; Michelle Kimbara; Pavel Shashkin; Jean F Charlot; Marianna Tcherpakov; Richard Corbett; Angela Tam; Richard Varhol; Duane Smailus; Michelle Moksa; Yongjun Zhao; Allen Delaney; Hong Qian; Inanc Birol; Jacqueline Schein; Richard Moore; Robert Holt; Doug E Horsman; Joseph M Connors; Steven Jones; Samuel Aparicio; Martin Hirst; Randy D Gascoyne; Marco A Marra
Journal:  Nat Genet       Date:  2010-01-17       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.